Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]
EMERGING TESTS
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
February 18, 2019
TESTING STRATEGY
PreOp Point-of-Care HbA1c Screening May Cut Complications
February 11, 2019
Point-of-care (POC) HbA1c measurements show a high level of agreement with central laboratory test in the outpatient setting, according to a small study published Jan. 18 in the Journal of Clinical … [Read more...]
INDUSTRY TRENDS
Point-of-Care PCR Tests Better Diagnosis, Rx for Kids’ Sore Throats
February 5, 2019
Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among pediatric patients presenting to the … [Read more...]
THE BUSINESS OF TESTING
Payer Medical Policies Can Promote Effective Use of Comprehensive Sequencing In Community Oncology Setting
January 22, 2019
Comprehensive genomic profiling (CGP) identifies clinically relevant genomic alterations that can be used to inform treatment decisions in community-based oncology practices that benefit both patients … [Read more...]
TESTING TRENDS
Low-Value, Blood Glucose Self-Monitoring is Common
January 21, 2019
A substantial percentage of patients with type 2 diabetes may be inappropriately self-monitoring blood glucose, according to a research letter published Dec. 10 in JAMA Internal Medicine. Despite … [Read more...]
GENETIC TESTING
Most Oncologists Report Using Sequencing-Based Panels In Practice
January 7, 2019
The majority of U.S. oncologists report using next-generation sequencing-based (NGS-based) tests to guide patient care, according to a study published Nov. 13 in JCO Precision Oncology, although use … [Read more...]
GUIDELINES
Pre-Op Urine Screening Not Necessary
December 31, 2018
Routine preoperative urine screening offers no clinical benefit, according to a large study published Dec. 12 in JAMA Surgery. Treating asymptomatic bacteriuria detected by screening does not cut the … [Read more...]
EMERGING TESTS
At-Home, Smartphone-Based Urine Testing Now a Clinical Reality
December 3, 2018
In what has been called the "era of the medical selfie," at-home, smartphone-based urine testing is now a reality. In a short timeframe, the U.S. Food and Drug Administration (FDA) cleared … [Read more...]
INDUSTRY TRENDS
Despite 23andMe Authorization, FDA Cautious About PGx Testing
November 26, 2018
The U.S. Food and Drug Administration (FDA) provided 23andMe (Mountain View, Calif.) authorization for the first direct-to-consumer (DTC) test for detecting genetic variants that may be associated … [Read more...]
GUIDELINES
Ideal Age of Last Cervical Cancer Screening Depends on Test Type
November 26, 2018
With the adoption of cotesting—human papillomavirus (HPV) plus Pap cytology—cervical cancer screening methodology has focused primarily on the preferred frequency of combined testing. However, a new … [Read more...]
